If you want to know why it’s so hard to fight the pharmaceutical industry and reduce spending on prescription drugs, pay close attention to a new Obama administration initiative and the reaction it’s getting on Capitol Hill — even from would-be allies in the Democratic Party.
The initiative seeks to change how Medicare pays for cancer therapies and other medications that physicians administer directly to patients in their offices or other outpatient settings. Under the current arrangement, Medicare basically reimburses doctors for the price of these drugs and then adds on an extra fee.
Read Full Article »